Investigational Site Number :1910001
Zagreb 10000
3 studies enrolling now · 7 studies all time
What they study most
Cerebroside Lipidosis Syndrome, Gaucher Disease, Giant Cell Arteritis, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Glycogen Storage Disease Type II, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency, Pompe Disease, Pompe Disease (Late-onset), Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Studies at this site
- Pompe Disease Registry Protocol — Recruiting now
- Pompe Pregnancy Sub-Registry — Recruiting now
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry — Recruiting now
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. — Running, not enrolling
- Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
- Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
- Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA — Stopped early